| Tanya Coles-dailey, LMSW | |
|
64 Palomba Dr Ste 2, Enfield, CT 06082-3850 | |
| (413) 244-0091 | |
| Not Available |
| Full Name | Tanya Coles-dailey |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 64 Palomba Dr Ste 2, Enfield, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306538897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4761 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tanya Coles-dailey, LMSW 64 Palomba Dr Ste 2, Enfield, CT 06082-3850 Ph: (413) 244-0091 | Tanya Coles-dailey, LMSW 64 Palomba Dr Ste 2, Enfield, CT 06082-3850 Ph: (413) 244-0091 |
News Archive
Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children's Center.
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
ThermoGenesis Corp. announced today it has signed a distribution agreement with Celling Technologies for ThermoGenesis' MarrowXpress (MXP(TM)) product line used for isolating stem cells from bone marrow. The distribution rights are for the field of use in orthopedic intraoperative or point-of-care applications.
Research carried out by scientists from the Peninsula Medical School at the University of Exeter and the National University of Singapore has analysed the complex 'cross talk' between hydrogen sulphide and nitric oxide, both gasses that occur naturally in the body, and found that the interaction may offer potential strategies in the management of heart failure.
› Verified 7 days ago
Judy Lavinski, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 47 Palomba Dr, Enfield, CT 06082 Phone: 860-253-5020 Fax: 860-253-5030 | |
Andrea Rebecca Curry, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 153 Hazard Ave, Enfield, CT 06082 Phone: 860-253-5020 Fax: 860-253-5030 | |
Sharon Petrone, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 153 Hazard Ave, Enfield, CT 06082 Phone: 860-253-5020 Fax: 860-253-5030 | |
Jennifer Bailey Resnick, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5 N Main St, Enfield, CT 06082 Phone: 602-539-0248 | |
James Greer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 47 Palomba Dr, Enfield, CT 06082 Phone: 860-253-5020 Fax: 860-253-5030 | |
Ms. Barbara L Brody, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 153 Hazard Ave, Enfield, CT 06082 Phone: 860-253-5020 | |
Mrs. Kathleen Ann Pariseau, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 153 Hazard Ave, Enfield, CT 06082 Phone: 860-731-5522 |